MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on December 2, 2004; DOI: 10.1124/mol.104.007559


0026-895X/05/6703-589-597$20.00
Mol Pharmacol 67:589-597, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow data supplement
Right arrow All Versions of this Article:
mol.104.007559v1
67/3/589    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wellendorph, P.
Right arrow Articles by Bräuner-Osborne, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wellendorph, P.
Right arrow Articles by Bräuner-Osborne, H.
ACCELERATED COMMUNICATION

Deorphanization of GPRC6A: A Promiscuous L-{alpha}-Amino Acid Receptor with Preference for Basic Amino Acids{boxs}

Petrine Wellendorph, Kasper B. Hansen, Anders Balsgaard, Jeremy R. Greenwood, Jan Egebjerg, and Hans Bräuner-Osborne

Department of Medicinal Chemistry, the Danish University of Pharmaceutical Sciences, Copenhagen, Denmark (P.W., K.B.H., A.B., J.R.G., H.B.-O.); and Department of Molecular Biology, H. Lundbeck A/S, Valby, Denmark (K.B.H., J.E.)

One of the most important tasks of molecular pharmacology is the deorphanization of the large number of G-protein-coupled receptors with unidentified endogenous agonists. We recently reported the cloning and analysis of expression of a novel human family C G-protein-coupled receptor, termed hGPRC6A. To identify agonists at this orphan receptor, we faced the challenges of achieving surface expression in mammalian cell lines and establishing an appropriate functional assay. Generating a chimeric receptor construct, h6A/5.24, containing the ligand binding amino-terminal domain (ATD) of hGPRC6A with the signal transducing transmembrane and C terminus of the homologous goldfish 5.24 receptor allowed us to overcome these obstacles. Homology modeling of the hGPRC6A ATD based on the crystal structure of the metabotropic glutamate receptor subtype 1 predicted interaction with {alpha}-amino acids and was employed to rationally select potential ligands. Measurement of Ca2+-dependent chloride currents in Xenopus laevis oocytes facilitated the deorphanization of h6A/5.24 and identification of L-{alpha}-amino acids as agonists. The most active agonists were basic L-{alpha}-amino acids, L-Arg, L-Lys, and L-ornithine, suggesting that these may function as endogenous signaling molecules. Measurement of intracellular calcium in tsA cells expressing h6A/5.24 allowed determination of EC50 values, which confirmed the agonist preferences observed in oocytes. Cloning, cell surface expression and deorphanization of the mouse ortholog further reinforces the assignment of the agonist preferences of hGPRC6A. This study demonstrates the utility of a chimeric receptor approach in combination with molecular modeling, for elucidating agonist interaction with GPRC6A, a novel family C G-protein-coupled receptor.


Received September 23, 2004; accepted December 2, 2004

Address correspondence to: Prof. Hans Bräuner-Osborne, Department of Medicinal Chemistry, The Danish University of Pharmaceutical Sciences, 2 Universitetsparken, DK-2100 Copenhagen, Denmark. E-mail: hbo{at}molpharm.net




This article has been cited by other articles:


Home page
J. Nutr.Home page
S. M. Morris Jr.
Arginine Metabolism: Boundaries of Our Knowledge
J. Nutr., June 1, 2007; 137(6): 1602S - 1609S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Choi, M. Lee, A. L. Shiu, S. J. Yo, and G. W. Aponte
Identification of a protein hydrolysate responsive G protein-coupled receptor in enterocytes
Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G98 - G112.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Kuang, Y. Yao, D. MacLean, M. Wang, D. R. Hampson, and B. S. W. Chang
From the Cover: Ancestral reconstruction of the ligand-binding pocket of Family C G protein-coupled receptors
PNAS, September 19, 2006; 103(38): 14050 - 14055.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Wang, Y. Yao, D. Kuang, and D. R. Hampson
Activation of Family C G-protein-coupled Receptors by the Tripeptide Glutathione
J. Biol. Chem., March 31, 2006; 281(13): 8864 - 8870.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Pi, P. Faber, G. Ekema, P. D. Jackson, A. Ting, N. Wang, M. Fontilla-Poole, R. W. Mays, K. R. Brunden, J. J. Harrington, et al.
Identification of a Novel Extracellular Cation-sensing G-protein-coupled Receptor
J. Biol. Chem., December 2, 2005; 280(48): 40201 - 40209.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Silve, C. Petrel, C. Leroy, H. Bruel, E. Mallet, D. Rognan, and M. Ruat
Delineating a Ca2+ Binding Pocket within the Venus Flytrap Module of the Human Calcium-sensing Receptor
J. Biol. Chem., November 11, 2005; 280(45): 37917 - 37923.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
N. Wettschureck and S. Offermanns
Mammalian G Proteins and Their Cell Type Specific Functions
Physiol Rev, October 1, 2005; 85(4): 1159 - 1204.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
O. Civelli
An Orphan Receptor Adopted by a Family of Transmitters
Mol. Pharmacol., March 1, 2005; 67(3): 583 - 584.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics